PIVA 08093930728
+39 0883 63 10 49 amministrazione@sestre.it
Via Oberdan, 9 76015 Trinitapoli (BT) Italy
Servizio Clienti
Account
Chi siamo
About
- Stories
- Community
- Blog
- Careers
- Brand Assets

Co-Founder & CEO | Pharmacist

Co-Founder | Biologist & Nutritionist

CMO | Growth Strategist Manager

COO | Omnichannel Content Creator
Sestre is a Femtech startup, that supports fertility and female hormonal balance thanks to a 360° approach. First of all, we study and market nutraceutical products based on extracts from the Mediterranean Diet, identifying epigenetic compounds to restore physiological pathways; then we follow our patients’ treatment through a digital platform which supports women in monitoring progress and giving them specialist assistance thanks to the Sestre scientific community.
Sestre operated in the nutraceutical integration field, addressing its offer to women between 20-45 years old who are looking for pregnancy and are suffering from chronic diseases that compromise their fertility and life quality.
Sestre offers a complete nutraceutical treatment to replace drug-based hormone therapy. Our nutraceutical products must follow our formulation approach which comprehends:
1. Choosing KM zero raw materials at least for 80% of ingredients;
2. Studying the synergies among Mediterranean Diet based nutrients to find epigenetics compounds;
3. Dosing each ingredient according to a homoeopathic approach;
4. Conducting studies based on in-vitro tests.
Sestre fertility treatment is also supported by a proprietary web platform which collects and analyses data from patients in order to provide customized aid in achieving their health goals. On the company hand, Sestre exploits these data collections to improve production and finds continuously new needs, reducing the risk of launching new products.
Fertility Supplements Market is worth around € 1.8bn and is growing strongly.
Compare to competitors, Sestre supplements are 100% Science Based. Our formulation are created from scientific papers and tested in vitrus with the University of Bari. Moreover, our Raw Material comes from KM0 Cultivation.
Supplements sales through the following channels:
proprietary e-commerce, Amazon and selected
channels;
pharmaceutical distributors pharmacies; content
strategy.
Sestre was founded in 2019.
2022: 150k from Public Financing “Tecnonidi”
BDG 2022: 120k
CAC: 24€
LTVC: 106€
Customers online: +1000
Distributors: +8
Direct Pharmacies: +40
Prescribers: +50
Round 2023-2024: 1M€
Round by the end of 2023: 500k€
18% Platform Dev
20% Marketing
22% HR
40% Sales
Ehy, keep in touch!
PIVA 08093930728
+39 0883 63 10 49 amministrazione@sestre.it
Via Oberdan, 9 76015 Trinitapoli (BT) Italy